Skip to main content

GSA CAPITAL PARTNERS LLP

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 1362033 LONDON, X0

Position in RIGL

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$295,466
-$887,906 QoQ
Shares Held
10,927
-73.8% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RIGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in RIGL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $295,466 10,927
2025-09-30 $1,183,372 41,771
2025-06-30 $766,450 40,921
2025-03-31 $803,901 44,686
2024-06-30 $741,813 90,245
2024-03-31 $2,041,704 1,379,530
2023-12-31 $2,069,210 1,427,042
2023-09-30 $1,049,156 971,441
2023-06-30 $462,627 358,626
2023-03-31 $428,205 324,398
2022-12-31 $142,903 95,269
2021-09-30 $417,580 115,036
2021-03-31 $54,867 16,043
2020-06-30 $154,505 84,429
2020-03-31 $351,853 225,547